Vascepa is a prescription medication that contains the active ingredient icosapent ethyl, which is a type of omega-3 fatty acid. It is used to reduce triglyceride levels in adults with severe hypertriglyceridemia [1]. According to the Drug Patent Watch website, the patent for Vascepa is set to expire in 2030, and no generic versions of the drug are currently available [1].

Medical News Today reports that Vascepa has been shown to be effective in reducing triglyceride levels in clinical trials. In one study, patients who took Vascepa experienced a 25% reduction in triglyceride levels compared to those who took a placebo [2]. The article also notes that Vascepa has been approved by the U.S. Food and Drug Administration (FDA) for use in reducing the risk of cardiovascular events in certain patients with elevated triglyceride levels [2].

In terms of cost, the official Vascepa website offers a savings program for eligible patients, which can help reduce the cost of the medication. The program offers a savings card that can be used to pay as little as $9 per month for Vascepa [3].

In summary, Vascepa is still an effective medication for reducing triglyceride levels in adults with severe hypertriglyceridemia. The drug is currently under patent and no generic versions are available. Vascepa has been shown to be effective in clinical trials and has been approved by the FDA for reducing the risk of cardiovascular events in certain patients. The Vascepa savings program can help eligible patients reduce the cost of the medication.

Sources:
[1] Drug Patent Watch. Vascepa. Retrieved from https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] Medical News Today. What to know about Vascepa. Retrieved from https://www.medicalnewstoday.com/articles/drugs-vascepa
[3] Vascepa. Vascepa Savings. Retrieved from https://www.vascepa.com/getting-started/vascepa-savings/